Report

European regulators recommend approval of Rasonque for pancreatic cancer

STAT reports the recommendation for Revolution Medicines’ drug followed an FDA green light.

1 Source, 26m ago, first seen 26m ago

TLDR

STAT reports that European regulators have recommended approval of Revolution Medicines’ pancreatic cancer drug Rasonque, following an FDA green light. The drug is now nearing European approval.

Today's Rank

#13

Combined views

659

1 Source, first seen 26m ago

1 Source

@statnewsFollowing a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer. https://trib.al/0Ww6pP21h

Today's Rank

#13

Combined views

659

1 Source, first seen 26m ago

1 likes

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Today's Rank

#13

Today's Rank

#13

1 likes

Featured Source

ST STAT@statnews 7:07 AM · Oct 16, 2026
Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer. https://trib.al/0Ww6pP2
STATRevMed's pancreatic cancer drug nears European approvalFollowing a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Featured Source

ST STAT@statnews 7:07 AM · Oct 16, 2026
Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer. https://trib.al/0Ww6pP2
STATRevMed's pancreatic cancer drug nears European approvalFollowing a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.